| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 587 | 2021 |
| Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines J Wei, KB Pouwels, N Stoesser, PC Matthews, I Diamond, R Studley, ... Nature medicine 28 (5), 1072-1082, 2022 | 182 | 2022 |
| Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom KD Vihta, KB Pouwels, TEA Peto, E Pritchard, T House, R Studley, ... MedRxiv, 2022 | 108* | 2022 |
| Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom KD Vihta, KB Pouwels, TEA Peto, E Prithard, DW Eyre, T House, ... Clinical Infectious Diseases, 2021 | 32 | 2021 |
| Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance E Pritchard, J Jones, KD Vihta, N Stoesser, PC Matthews, DW Eyre, ... The Lancet Regional Health-Europe 13, 100282, 2022 | 16 | 2022 |
| SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population (preprint) J Wei, KB Pouwels, N Stoesser, PC Matthews, I Diamond, R Studley, ... | 13 | 2021 |
| Lineage replacement and evolution captured by the United Kingdom Covid Infection Survey KA Lythgoe, T Golubchik, M Hall, T House, G MacIntyre-Cockett, H Fryer, ... MedRxiv, 2022 | 10 | 2022 |
| SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection J Wei, P Matthews, N Stoesser, I Diamond, R Studley, E Rourke, D Cook, ... Nature Communications, 2022 | 9 | 2022 |
| COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK J Buckell, J Jones, PC Matthews, SI Diamond, E Rourke, R Studley, ... medRxiv [Internet], 2021 | 6 | 2021 |
| SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population J Wei, KB Pouwels, N Stoesser, PC Matthews, I Diamond, R Studley, ... medRxiv, 2021 | 4 | 2021 |
| Monitoring populations at increased risk for SARS-CoV-2 infection in the community E Pritchard, J Jones, K Vihta, N Stoesser, PC Matthews, DW Eyre, ... medRxiv, 2021 | 3 | 2021 |
| COVID-19 vaccination, risk-compensatory behaviours, and social contacts in four countries in the UK J Buckell, J Jones, PC Matthews, I Diamond, E Rourke, R Studley, D Cook, ... medRxiv, 2021 | 1 | 2021 |
| Symptoms and SARS-CoV-2 positivity in the general population in the UK KD Vihta, KB Pouwels, T Peto, E Pritchard, DW Eyre, T House, O Gethings, ... Medrxiv, 2021 | | 2021 |
| The challenge of limited vaccine supplies: impact of prior infection on anti-spike IgG antibody trajectories after a single COVID-19 vaccination J Wei, P Matthews, N Stoesser, I Diamond, R Studley, E Rourke, D Cook, ... medRxiv, 2021 | | 2021 |
